Key summary points
The aim of this study was to investigate the impact of aspiration pneumonia and other prognostic factors that affect long-term and functional outcomes in older patients with pneumonia.
AbstractSection FindingsMortality was significantly higher in aspiration pneumonia than non-aspiration pneumonia during admission and at 1 year. However, independent risk factors for poor prognosis were old age, frailty and cardio-respiratory comorbidities and not the initial diagnosis of aspiration pneumonia.
AbstractSection MessageThe management of older adults with pneumonia must be based on frailty and overall condition rather than the potentially futile labelling of aspiration pneumonia or non-aspiration pneumonia.
Abstract
Purpose
Little is known about the long-term and functional prognoses of older adults with pneumonia, which complicates their management. There is a common belief that aspiration is a poor prognostic factor; however, the diagnosis of aspiration pneumonia (AP) lacks consensus criteria and is mainly based on clinical characteristics typical of the frailty syndrome. Therefore, the poor prognosis of AP may also be a result of frailty rather than aspiration. This study investigated the impact of AP and other prognostic factors in older patients with pneumonia.
Methods
We performed a retrospective cohort study of patients aged 75 years and older, admitted with pneumonia in 2021. We divided patients according to their initial diagnosis (AP or non-AP), compared outcomes using Kaplan–Meier curves, and used logistic regression to identify independent prognostic factors.
Results
803 patients were included, with a median age of 84 years and 52.7% were male. 17.3% were initially diagnosed with AP. Mortality was significantly higher in those diagnosed with AP than non-AP during admission (27.6% vs 19.0%, p = 0.024) and at 1 year (64.2% vs 53.1%, p = 0.018), with survival analysis showing a median survival time of 62 days and 274 days in AP and non-AP, respectively (χ2 = 9.2, p = 0.002). However, the initial diagnosis of AP was not an independent risk factor for poor prognosis in multivariable analysis. Old age, frailty and cardio-respiratory comorbidities were the main factors associated with death.
Conclusion
The greater mortality in AP may be a result of increased frailty rather than the diagnosis of aspiration itself. This supports our proposal for a paradigm shift from making predictions based on the potentially futile labelling of AP or non-AP, to considering frailty and overall condition of the patient.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
As Sir William Osler, the founding father of modern medicine, wrote in his first medical textbook in 1892, pneumonia is often regarded as ‘the special enemy of old age’ [1]. By the third edition of his book, he rephrased this to the well-known quote: “Pneumonia may well be called the friend of the aged” [2]. Interestingly, these contradictory statements both describe the same characteristic of pneumonia in older adults: its high mortality. Despite revolutionary advances in the diagnosis, treatment and prevention of pneumonia, the comparatively high mortality of pneumonia in older adults has remained unchanged.
Predicting the prognosis of older patients with pneumonia is essential for the optimal treatment and, where appropriate, a palliative approach [3]. However, the multifactorial pathophysiology of pneumonia in older adults makes prediction difficult. Traditional pneumonia severity indicators recommended by guidelines such as CURB-65 [4], pneumonia severity index (PSI) [5], and A-DROP [6] have been reported to be less useful in this population [7,8,9]. In pneumonia in older adults, where up to 90% of cases may be aspiration-related [10], the severity of the lung inflammation itself is not the sole determinant of prognosis. Rather, their prognosis is a result of a complex combination of comorbidities [11, 12], frailty, sarcopenia, malnutrition, poor oral hygiene, oral frailty, and impaired immune responses. This is why we previously proposed the term ‘Frailty associated pneumonia (FAP)’ [13]. Some reported poor prognostic factors include multimorbidity, aspiration, reduced cough effectiveness, malnutrition, older age, higher dependency, loss of muscle mass and anticholinergic drugs [12,13,14,15,16,17,18,19,20,21,22,23,24]. No clear prognostic factors have been identified for pneumonia in older adults, despite the high disease prevalence and mortality.
In our previous studies, we revealed a lack of unified diagnostic criteria for aspiration pneumonia (AP) in both literature [25] and clinical practice [26], and the reality that older adults with pneumonia were labelled as AP or non-AP depending on comorbidities and baseline frailty [26]. Their management differed according to the initial diagnosis; patients diagnosed with AP were less likely to be investigated, but more likely to be made nil by mouth (NBM) and treated with broad-spectrum antibiotics, whilst those diagnosed with non-AP were more likely to be investigated for alternative diagnoses. These initial diagnoses and differences in management may influence outcomes. Although it is generally accepted that the prognosis is worse in AP than non-AP, this may be due to confounding factors such as frailty and comorbidities rather than aspiration itself. Frailty is a particularly important factor affecting prognosis in cancer and heart failure amongst other conditions [27,28,29]. There is a need to assess AP and its independent impact on prognosis amongst other risk factors including frailty.
Furthermore, when discussing prognosis, it is not only the short-term prognosis that is of interest in clinical practice. Long-term mortality after an episode of pneumonia is also high in older adults [30, 31], and survivors have been reported to be at risk of functional decline [32]. To discuss the optimal care for the patient, it is essential to make an evidence-based prediction of their long-term prognosis and the impact of pneumonia on their quality of lives. Despite the large number of studies on the immediate outcomes of patients with pneumonia, long-term prognosis and functional outcomes are rarely discussed, and there is a lack of large studies based in the UK or European countries.
Therefore, following our initial study on the diagnosis and management of older patients admitted with pneumonia [26], we now report on their prognosis and the impact of AP amongst other associated factors to identify poor prognostic factors, with a particular focus on long-term and functional outcomes.
Methods
Study design
This was the one-year follow-up of a retrospective cohort study of patients admitted with pneumonia to Queen Elizabeth Hospital (Lewisham and Greenwich NHS Trust). Ethical approval was obtained from the Lewisham and Greenwich NHS Trust (Number 7211), and informed consent was waived due to the retrospective nature of the study. Detailed inclusion and exclusion criteria, data collection methods, and patient selection process are described in our previous paper [26]. Briefly, we included patients aged 75 years and older admitted with community-acquired pneumonia (CAP) in 2021, excluding those admitted for COVID-19. We collected data on the patient background, comorbidities, presenting condition, and outcome from medical records.
Data collection
We used the following data collected for our previous study: patient demographics (age, sex), social history (whether they lived at home or in a care/nursing home, and whether they had professional carers or not), medical history (comorbidities, drugs, pneumonia within the past year), presenting condition (CURB-65 score [4], pneumonia severity index (PSI) [5], clinical frailty score (CFS) [33], and initial diagnosis (AP or non-AP). The initial diagnosis was extracted according to what was documented on the consultant physician ward round at the time of admission. This was because our study intended to investigate the reality of how AP was being diagnosed in clinical practice. Non-AP was defined as any patient diagnosed with CAP that was not documented as AP. In addition, we extracted the following outcome data from the medical records: survival at the time of discharge and 1 year after admission, level of dependence at discharge, recurrence of pneumonia within 1 month after admission, and length of hospital stay (days). In the UK, community medical records can be partially accessed from the hospital medical record system, allowing us to assess the patients’ date of death. We categorised the level of dependence into the following five levels, with 1 being the least dependent and 5 being the most dependent: (1) living at home alone, (2) living at home alone with arranged professional carers, (3) living with family (with/without arranged professional carers), (4) living in a residential home, and (5) living in a nursing home. The need for increased support (moving from a lower to a higher category) was defined as ‘increased level of dependence’. Amongst the potential risk factors for poor outcomes, we selected the following, based on the results of our previous study [26] and other reports: age, sex, social history (according to the level of dependence explained above), neurological condition (stroke or degenerative neurological disorder/disease), dementia, cardiac condition (ischaemic or congestive heart disease), diabetes mellitus, chronic respiratory disorder, CRIDECO anticholinergic load scale (CALS), history of pneumonia within 1 year prior to admission, CFS, CURB-65, initial diagnosis of AP, being put on nil by mouth (NBM) on admission, and a speech and language therapist (SLT) referral.
Statistical analyses
We used chi-square tests to compare AP and non-AP diagnostic groups for the outcomes of mortality (overall, in-hospital and after discharge up to one year from admission), 30-day pneumonia recurrence and increased dependency level, and a t-test for the continuous outcomes of length of stay (days). We performed survival analysis for mortality at 12 months, and compared median survival time across AP and non-AP diagnoses with Kaplan–Meier curves.
Logistic regression was used to calculate adjusted estimates for the AP diagnostic group and to identify additional prognostic factors that were included in the covariates listed in the Data Collection section. We also conducted multiple linear regression on the continuous outcome of length of hospital stay (days). Analyses were performed using Microsoft Excel and the survival and survminer packages [34, 35] in R. A p value < 0.05 was considered to be statistically significant for all analyses.
Results
Patient background
A total of 803 patients were included in the study. Demographical data are shown in Table 1. There were 423 males (52.7%), with a median age of 84 years (interquartile range: 80–89). One hundred and thirty-nine patients (17.3%) were initially diagnosed with AP. As discussed in our previous study, AP tended to be diagnosed on the basis of frailty and comorbidities rather than the assessment of swallowing, cough or oral hygiene [26]. This was derived from the fact that the initial diagnosis of AP or non-AP was done prior to any assessments by SLTs, and there was no mention of swallow screening tests or oral hygiene status before or at the timing of pneumonia diagnosis. Other details on patient background and intervention are explained in our previous study [26].
Outcomes
Differences in outcomes between diagnostic groups are shown in Table 2. The mortality rate during admission was significantly higher in the AP group than in the non-AP group (27.6% vs 19.0%, p = 0.024). Similarly, the mortality rate at 1 year after admission was significantly higher in the AP group than in the non-AP group (64.2% vs 53.1%, p = 0.018). There was no significant difference between the groups for death after discharge, increased dependency, 30-day pneumonia recurrence, or length of hospital stay.
Risk factors for poor outcome
The full results of the logistic regression are shown in the supplementary table. In summary, the odds of in-hospital death were significantly higher for older age, history of pneumonia in the previous year, presence of cardiac condition, higher CURB-65 score and NBM on admission. Amongst survivors at discharge, the odds of death within 1 year of admission were significantly higher for older age, respiratory condition, and a higher CFS score. The odds of death within 1 year of admission overall were significantly higher for older age, respiratory condition, a history of pneumonia in the previous year, a higher CFS score, a higher CURB-65 score, being made NBM on admission, and having a speech therapy referral. A diagnosis of AP (as opposed to non-AP) was not an independent risk factor of either poor outcome after controlling for severity, comorbidities and age.
We performed analysis regarding the dependency level on 640 patients who had not died in the hospital and found that the odds of increased dependency at discharge were significantly higher depending on a higher CFS score, higher CURB-65 score, being made NBM on admission, and having an SLT referral. On the other hand, higher dependence at admission and neurological conditions may be related with a more favourable outcome. Again, a diagnosis of AP was not an independent risk factor for poor functional outcome.
Likewise, we performed an analysis of pneumonia recurrence in the 639 patients who were discharged alive within 30 days. The odds ratio for pneumonia recurrence within 30 days of admission was significantly higher in those with a pneumonia history in the previous year, and those with an SLT referral. A diagnosis of AP was not amongst the independent risk factors.
Kaplan–Meier curves for 1-year survival are shown in Fig. 1, which revealed a median of 274 days to death for a non-AP diagnosis and 62 days for an AP diagnosis (χ2 = 9.2, p = 0.002), with survival curves indicating that this appeared to be primarily a result of a more rapid death rate associated with an AP diagnosis in the early stages after admission.
Figure 2 shows the causes of death in the hospital and after discharge (within 1 year). The leading cause of death in both groups remained pneumonia, whilst the second most common cause of death in hospital was cardiologic conditions such as ischaemic heart disease and congestive heart failure. Causes that increased after discharge included more chronic conditions such as cancer, frailty and neurological disorders. There were no significant differences in the causes of death between the AP and non-AP groups.
Discussion
In older adults with pneumonia, whilst age was understandably a common risk factor for poor prognosis, independent risk factors differed between outcomes. Frailty was a common independent risk factor for poor long-term and functional outcomes. These data provide valuable insight into the prediction of patient-relevant outcomes and enable more informed decision-making regarding their care.
The most important finding to highlight is that although patients diagnosed with AP had significantly worse survival than those with non-AP (Fig. 1), this diagnosis was not an independent risk factor in any of the five outcomes analysed, after controlling for other factors (supplementary table). Rather, age, cardiorespiratory comorbidities, and a higher CFS score were independent risk factors. This suggests that what affects survival is the general condition rather than aspiration. This is consistent with the reality that the diagnosis of AP in older adults has evolved into a diagnosis of frailty, as discussed in our previous studies [13, 25, 26], and other related studies [36]. Clinicians tend to provide a clinical diagnosis of AP in the more severely frail and those with more comorbidities; hence it is natural that patients diagnosed with AP have a poor prognosis. Our results highlight the importance of considering the patient’s frailty and comorbidities and not just the diagnostic label when predicting prognosis and deciding management.
The overall mortality rate during admission in older adults hospitalised with CAP was 20.4%, which is higher than the younger population [37]. Older age and cardiac comorbidities are previously reported risk factors for poor prognosis, whilst a history of pneumonia in the previous year is a new important risk factor. Those who were NBM on admission had a high OR of 4.96, likely reflecting their severe condition on admission and not necessarily a prognostic factor. Similarly, the effects of CURB-65 must be interpreted with caution, as there was no difference in the median CURB-65 score amongst the two groups. Interestingly, dementia was associated with a favourable short-term prognosis. This may be partly because admission in those with a history of dementia is driven by delirium rather than the severity of pneumonia.
During the first year after admission, 54.9% of patients died. Even after being discharged alive, 43.3% had died in the first year after admission. This is a significant figure that must be borne in mind when managing these patients. The survival curve in Fig. 1 shows that most of these deaths occurred within the first few weeks of admission. Those diagnosed with AP had a significantly worse prognosis, but interestingly, after a few months, the survival curves of AP and non-AP appear to become parallel. A similar dissociation of survival curves between AP and non-AP was also observed in a recent study in France [38], in which frailty was not compared between groups. It can be spectated that frail patients (who were more likely to be diagnosed with AP) were more likely to die after an acute episode of pneumonia, as shown in Fig. 2 where frailty and neurological conditions were amongst the common causes of death after discharge.
Factors that adversely affected long-term survival were older age, respiratory disorder, and a higher CFS score, of which the latter two were not associated with short-term survival, indicating that frailty and comorbidities affect the survival of patients after recovery from pneumonia, regardless of the severity of pneumonia.
Pneumonia recurred within 30 days of admission in 13% of those who had initially recovered. A history of pneumonia in the previous year and SLT referral were independently associated with recurrence, but other factors commonly considered to be risk factors (such as AP or diabetes mellitus) were not.
Amongst survivors, 23.3% had an increased dependence level at discharge. Independent risk factors related to increased dependence level were frailty, more severe pneumonia, and SLT referral. On the other hand, a higher dependence level at admission and neurological conditions were related to favourable outcomes. This may be because these patients already had a high dependence level (living with family or carers). It is clinically important to identify patients at risk of functional decline early and initiate physiotherapy to avoid preventable loss of mobility [39, 40].
These study findings have many clinical implications. The poor prognosis of older patients admitted with pneumonia must be kept in mind, with one in five patients dying during the hospital stay, and a quarter of survivors being discharged with increased dependence, and nearly half of survivors dying within the next year. Whilst short-term survival is the imminent factor for clinicians when treating a patient with pneumonia, it is not the only concern for patients and their families. When predicting prognosis and communicating future outlook and management options with patients and their families, clinicians must consider increased dependence and long-term prognosis too. Discussion of treatment escalation plans and community care would be particularly important for more frail patients and those with comorbidities such as respiratory conditions, and a multidisciplinary team approach is the key to adequate management and shared-decision making.
Another important finding is that the general condition of the patient seems to independently affect the outcome more than the diagnosis of AP itself. This supports our previous proposal of a paradigm shift in the management of pneumonia in older adults, from the potentially futile labelling of AP or non-AP to considering frailty and the overall condition of the patient [26]. However, this is a preliminary interpretation from an observational study and would need to be confirmed by a randomised controlled trial before any further conclusions could be drawn. In the meantime, it is safe to say that our common practice of making patients NBM is best considered carefully, depending on the individual patient’s condition. Eating and drinking are a vital source of nutrition and hydration for these patients, as well as being an important factor in their quality of lives. Patients should be assessed for swallowing and oral hygiene and encouraged to continue oral intake as appropriate.
These findings also have research implications, as the long-term prognosis and prognostic factors are not yet known. With advances in electronical medical records and technology, larger database studies looking at long-term prognosis are needed.
There were limitations associated with this study, mainly owing to the single-centre, retrospective design. In particular, data on deaths after discharge may not have been available in the medical record system if they occurred outside of the local NHS Trust, meaning that there may have been more deaths. However, this was a relatively large study with an initial list of over 1400 patients with pneumonia, from a large acute hospital. The majority of older adults admitted will continue to be treated by the same NHS Trust after discharge. There have been no similar studies of older adults diagnosed with pneumonia in the UK, highlighting the importance of this study. We believe this is a meaningful step in addressing the challenging conundrum of the diagnosis and management of AP. In future studies, it would be useful to assess data prospectively and assess frailty in a more robust and accurate way.
Conclusion
AP was associated with much greater mortality, with survival analysis showing a median survival of 62 days compared to 274 days in the non-AP group. However, multivariable regression showed that greater mortality in AP may be a simple function of increased frailty rather than the diagnosis of aspiration itself. Older adults with a diagnosis of pneumonia not only have a poor short-term prognosis but also poor long-term and functional outcomes. Survivors are at high risk of becoming increasingly dependent, and many die within the following months. This supports our proposal for a paradigm shift in the focus of clinicians managing older adults with pneumonia, from making predictions and decisions based on the potentially futile labelling of AP or non-AP, to considering frailty and overall condition of the patient. It is crucial to consider patient-relevant outcomes and associated risk factors when managing older adults with pneumonia.
Data availability
All data are applicable in the paper.
References
Osler W (1892) The principles and practice of medicine, designed for the use of practitioners and students of medicine, 1st edn. D. Appleton and Company, New York
Osler W (1898) The principles and practice of medicine, designed for the use of practitioners and students of medicine, 3rd edn. Young J. Pentland, Edinburgh
Yoshimatsu Y, Ohtake Y, Ukai M, Miyagami T, Morikawa T, Shimamura Y, Kataoka Y, Hashimoto T (2023) “Diagnose, Treat, and SUPPORT”. Clinical competencies in the management of older adults with aspiration pneumonia: a scoping review. Eur Geriatr Med. https://doi.org/10.1007/s41999-023-00898-4
Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58(5):377–382
Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE et al (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336(4):243–250
Yanagihara K, Kohno S, Matsusima T (2001) Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents 18(Suppl 1):S45–S48
Chen JH, Chang SS, Liu JJ, Chan RC, Wu JY, Wang WC et al (2010) Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults, elderly and very old subjects. Thorax 65(11):971–977
Lanspa MJ, Jones BE, Brown SM, Dean NC (2013) Mortality, morbidity, and disease severity of patients with aspiration pneumonia. J Hosp Med 8(2):83–90
Ugajin M, Yamaki K, Hirasawa N, Kobayashi T, Yagi T (2014) Prognostic value of severity indicators of nursing-home-acquired pneumonia versus community-acquired pneumonia in elderly patients. Clin Interv Aging 9:267–274
Teramoto S, Fukuchi Y, Sasaki H, Sato K, Sekizawa K, Matsuse T et al (2008) High incidence of aspiration pneumonia in community- and hospital-acquired pneumonia in hospitalized patients: a multicenter, prospective study in Japan. J Am Geriatr Soc 56(3):577–579
Hamaguchi S, Suzuki M, Sasaki K, Abe M, Wakabayashi T, Sando E et al (2018) Six underlying health conditions strongly influence mortality based on pneumonia severity in an ageing population of Japan: a prospective cohort study. BMC Pulm Med 18(1):88
Yoon HY, Shim SS, Kim SJ, Lee JH, Chang JH, Lee SH et al (2019) Long-term mortality and prognostic factors in aspiration pneumonia. J Am Med Dir Assoc 20(9):1098–104 e4
Smithard DG, Yoshimatsu Y (2022) Pneumonia, aspiration pneumonia, or frailty-associated pneumonia? Geriatrics (Basel) 7(5):115
Rodriguez AE, Restrepo MI (2019) New perspectives in aspiration community acquired pneumonia. Expert Rev Clin Pharmacol 12(10):991–1002
Gupte T, Knack A, Cramer JD (2022) Mortality from aspiration pneumonia: incidence, trends, and risk factors. Dysphagia 37:1493–1500
Ebihara T, Miyamoto T, Kozaki K (2020) Prognostic factors of 90-day mortality in older people with healthcare-associated pneumonia. Geriatr Gerontol Int 20(11):1036–1043
Araki T, Yamazaki Y, Goto N, Takahashi Y, Ikuyama Y, Kosaka M (2022) Prognostic value of geriatric nutritional risk index for aspiration pneumonia: a retrospective observational cohort study. Aging Clin Exp Res 34(3):563–571
Bosch X, Formiga F, Cuerpo S, Torres B, Roson B, Lopez-Soto A (2012) Aspiration pneumonia in old patients with dementia. Prognostic factors of mortality. Eur J Intern Med 23(8):720–726
Maeda K, Akagi J (2017) Muscle mass loss is a potential predictor of 90-day mortality in older adults with aspiration pneumonia. J Am Geriatr Soc 65(1):e18–e22
Taylor JK, Fleming GB, Singanayagam A, Hill AT, Chalmers JD (2013) Risk factors for aspiration in community-acquired pneumonia: analysis of a hospitalized UK cohort. Am J Med 126(11):995–1001
Lee CY, Cheng YD, Cheng WY, Tsai TH, Huang KH (2020) The prevalence of anticholinergic drugs and correlation with pneumonia in elderly patients: a population-based study in Taiwan. Int J Environ Res Public Health 17(17):6260
Chatterjee S, Carnahan RM, Chen H, Holmes HM, Johnson ML, Aparasu RR (2016) Anticholinergic medication use and risk of pneumonia in elderly adults: a nested case-control study. J Am Geriatr Soc 64(2):394–400
Paul KJ, Walker RL, Dublin S (2015) Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based case-control study. J Am Geriatr Soc 63(3):476–485
Takada K, Ogawa K, Miyamoto A, Nakahama H, Moriguchi S, Murase K et al (2023) Risk factors and interventions for developing recurrent pneumonia in older adults. ERJ Open Res. https://doi.org/10.1183/23120541.00516-2022
Yoshimatsu Y, Melgaard D, Westergren A, Skrubbeltrang C, Smithard DG (2022) The diagnosis of aspiration pneumonia in older persons: a systematic review. Eur Geriatr Med 13:1071–1080
Yoshimatsu Y, Smithard DG (2022) A paradigm shift in the diagnosis of aspiration pneumonia in older adults. J Clin Med 11(17):5214
Cai M, Gao Z, Liao J, Jiang Y, He Y (2022) Frailty affects prognosis in patients with colorectal cancer: a systematic review and meta-analysis. Front Oncol 12:1017183
Dai S, Yang M, Song J, Dai S, Wu J (2021) Impacts of frailty on prognosis in lung cancer patients: a systematic review and meta-analysis. Front Med (Lausanne) 8:715513
Pandey A, Kitzman D, Reeves G (2019) Frailty is intertwined with heart failure: mechanisms, prevalence, prognosis, assessment, and management. JACC Heart Fail 7(12):1001–1011
Mortensen EM, Kapoor WN, Chang CC, Fine MJ (2003) Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis 37(12):1617–1624
Eurich DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR (2015) Ten-year mortality after community-acquired pneumonia. A prospective cohort. Am J Respir Crit Care Med 192(5):597–604
Chen H, Hara Y, Horita N, Saigusa Y, Hirai Y, Kaneko T (2022) Is rehabilitation effective in preventing decreased functional status after community-acquired pneumonia in elderly patients? Results from a multicentre, retrospective observational study. BMJ Open 12(9):e051307
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I et al (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489–495
Kassambara A, Kosinski M, P B. Survminer: drawing survival curves using ‘ggplot2’_ 2021. R package version 0.4.9. https://CRAN.R-project.org/package=survminer.
Therneau TM. A package for survival analysis in R_ 2022. R package version 3.4–0. https://CRAN.R-project.org/package=survival.
Hibberd J, Fraser J, Chapman C, McQueen H, Wilson A (2013) Can we use influencing factors to predict aspiration pneumonia in the United Kingdom? Multidiscip Respir Med 8(1):39
Theilacker C, Sprenger R, Leverkus F, Walker J, Hackl D, von Eiff C et al (2021) Population-based incidence and mortality of community-acquired pneumonia in Germany. PLoS ONE 16(6):e0253118
Putot A, Putot S, Manckoundia P (2023) Long-term survival after aspiration pneumonia in older inpatients: a comparative study. J Am Med Dir Assoc 24:1088–1091
Momosaki R, Yasunaga H, Matsui H, Horiguchi H, Fushimi K, Abo M (2015) Effect of early rehabilitation by physical therapists on in-hospital mortality after aspiration pneumonia in the elderly. Arch Phys Med Rehabil 96(2):205–209
Yagi M, Yasunaga H, Matsui H, Fushimi K, Fujimoto M, Koyama T et al (2016) Effect of early rehabilitation on activities of daily living in patients with aspiration pneumonia. Geriatr Gerontol Int 16(11):1181–1187
Funding
Japanese Respiratory Society (2021).
Author information
Authors and Affiliations
Contributions
YY and DGS had the study conception and designed the study. YY and HT collected the data, YY and TT analysed the data, and all authors interpreted the data. YY and TT drafted the article, and HT and DGS critically revised it. All authors approved the final product.
Corresponding author
Ethics declarations
Competing interests
The corresponding author is supported by The Japanese Respiratory Society Fellowship Grant. The sponsor had no role in this study design, review process, writing of the manuscript, or decision to publish. The authors received no other financial support for the research, authorship and publication of this article. The authors declare that they have no other competing interests.
Ethics approval
Ethical approval was obtained from the Lewisham and Greenwich NHS Trust (Number 7211).
Informed consent
Informed consent was waived due to the retrospective nature of the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yoshimatsu, Y., Thomas, H., Thompson, T. et al. Prognostic factors of poor outcomes in pneumonia in older adults: aspiration or frailty?. Eur Geriatr Med 15, 481–488 (2024). https://doi.org/10.1007/s41999-023-00929-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41999-023-00929-0